Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis - Wikidata - awgldk - TriplyDB

Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis

Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis

http://www.wikidata.org/entity/Q35554303

about

Joint inflammation and early degeneration induced by high-force reaching are attenuated by ibuprofen in an animal model of work-related musculoskeletal disorder Pain reduction with oral methotrexate in knee osteoarthritis, a pragmatic phase iii trial of treatment effectiveness (PROMOTE): study protocol for a randomized controlled trial.Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenac Predictive validity of biochemical biomarkers in knee osteoarthritis: data from the FNIH OA Biomarkers Consortium.The role of synovitis in osteoarthritis.Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis Application of biomarkers in the clinical development of new drugs for chondroprotection in destructive joint diseases: a review.Efficacy of treatment with glucosamine sulfate in patients with knee effusion due to osteoarthritis.Collagen biomarkers for arthritis applications.Application of biochemical markers in development of drugs for treatment of osteoarthritis.Osteoarthritis of the knee and hip. Part II: therapy with ibuprofen and a review of clinical trials.Meniscal biology in health and disease.In vitro evaluation of S-(+)-ibuprofen as drug candidate for intra-articular drug delivery system.Does long term colchicine prevent degradation of collagen fiber network in osteoarthritis?Effect of mud compress therapy on cartilage destruction detected by CTX-II in patients with knee osteoarthritis.

P2860

Q23914570-761F63F5-7E63-4308-9E29-414A5615D388 Q35154188-DDF28AAC-F2BB-49E4-8058-040746EA3C1C Q35637500-936FF2B3-10AA-4E7D-A910-ED289A0D327D Q36050803-0935C1D1-8B3C-4547-8FCB-263D7A91A376 Q36059419-4A5C359A-52A0-439F-B77B-FDB6BF627AC8 Q36598469-E3ADAC38-1A40-4222-817D-CE1B6053D3C2 Q36631211-BEC9CDA9-A0EA-4BA4-A2E7-5C8FDEB2A22F Q37258062-566868C8-D35C-4175-AF41-7B291126F9AB Q37277952-06C28CF4-2154-417B-8FF2-730AE2E148D0 Q37677789-B2C8E45E-E64F-4952-AFF8-07B67BD1FA3C Q37999393-9862FBE2-52C6-4CC1-8FE9-7508E3331BDC Q39313209-195C49A9-6CC6-405E-AD3A-09FAFE045400 Q46749116-31E36415-2546-4A4D-BE6A-2F93A9AC14D0 Q50860861-F6263D59-4F34-45FE-AAA3-78FF9CEDAD08 Q53338113-35890C73-A893-4637-B3DB-E4BDF3B65FB4

P2860

Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis

http://www.wikidata.org/entity/Q35554303

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Effects of ibuprofen on molecu ...... ients with knee osteoarthritis

@ast

Effects of ibuprofen on molecu ...... ients with knee osteoarthritis

@en

type

label

Effects of ibuprofen on molecu ...... ients with knee osteoarthritis

@ast

Effects of ibuprofen on molecu ...... ients with knee osteoarthritis

@en

prefLabel

Effects of ibuprofen on molecu ...... ients with knee osteoarthritis

@ast

Effects of ibuprofen on molecu ...... ients with knee osteoarthritis

@en

P1433

Q35554303-97C313E2-DC41-48DF-8544-9EB9AFCAFA42

P1476

Q35554303-D73E597C-DFED-4F1F-98C5-EB349DE72418

P2093

Q35554303-307FBB01-29EA-44AE-A043-2261412FE71A

Q35554303-3104DE37-D01F-4E4C-B801-FDD217D9D885

Q35554303-75929556-E4E1-4FA5-A3DD-C07A0061D99D

Q35554303-854200E6-F5F4-4B20-B899-4210AD5020EE

Q35554303-A056BB15-904B-472F-A024-3AABD14198A3

Q35554303-A4921035-4371-4601-BC25-4865CF039350

Q35554303-B69472B4-2630-42B7-8942-5D537C5F113B

Q35554303-FDD371FB-2ADD-4B17-9332-05C12F51254C

P2860

Q35554303-0AA2E5E1-EDB1-4661-B39A-1BD50AC71CAA

Q35554303-0CE3A7F7-D7C3-4163-8816-CDB4903385E8

Q35554303-1212E872-696C-410F-9CF3-129CBB139BC4

Q35554303-1DDE3064-8A2A-422B-AC72-60D47D1F1456

Q35554303-2804F5C1-8AE3-45B6-9690-E99F3FC36999

Q35554303-30C02643-F8F8-4578-97B7-959BC6312E8D

Q35554303-3542A160-62E3-4CE7-A137-B4BD15D529E8

Q35554303-357D300A-006B-4433-86D2-0DE348501752

Q35554303-60A0869F-04DF-44A8-B5D5-AF57AC4F715A

Q35554303-7E50A196-8061-4CE1-A718-91BE8708EBF4

P304

Q35554303-205F4006-151A-4BA0-AAD5-46239A9FAB35

P31

Q35554303-603750A8-B9E0-4F40-B864-683644664CA5

P356

Q35554303-7ADE34B8-4553-4E42-9D40-EAD97EF601C2

P407

Q35554303-2C3D1386-5BAD-47C4-8146-47AEC08ABF43

P433

Q35554303-8E701974-ABFE-4466-8CD3-1A1DC1C9A4CD

P478

Q35554303-96D247F4-DE13-4AB4-88F2-F396162F8DF2

P577

Q35554303-26576473-41E8-463D-9F76-B55193DC79DC

P5875

Q35554303-39EC61D9-7F14-4E68-8C7C-C801242A8A67

P698

Q35554303-C817D6C0-7467-4006-81BC-8064A8E9AB14

P932

Q35554303-3DCC5FFF-1523-4916-80EF-BAE1EE9438A3

P356

ARD.2003.007302

P1433

Annals of the Rheumatic Diseases

P1476

Effects of ibuprofen on molecu ...... ients with knee osteoarthritis

@en

P2093

Curtis SP

http://www.w3.org/2001/XMLSchema#string

Delmas PD

http://www.w3.org/2001/XMLSchema#string

Garnero P

http://www.w3.org/2001/XMLSchema#string

Gertz BJ

http://www.w3.org/2001/XMLSchema#string

Gineyts E

http://www.w3.org/2001/XMLSchema#string

Henriksen DB

http://www.w3.org/2001/XMLSchema#string

Ko A

http://www.w3.org/2001/XMLSchema#string

Mo JA

http://www.w3.org/2001/XMLSchema#string

P2860

Partial chondroprotective effect of zoledronate in a rabbit model of inflammatory arthritis.

Osteoarthritis: new insights. Part 1: the disease and its risk factors.

Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases.

Aceclofenac: a reappraisal of its use in the management of pain and rheumatic disease.

Effects of diclofenac, aceclofenac and meloxicam on the metabolism of proteoglycans and hyaluronan in osteoarthritic human cartilage.

Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.

Variability in knee radiographing: implication for definition of radiological progression in medial knee osteoarthritis.

Urinary excretion of glucosyl-galactosyl pyridinoline: a specific biochemical marker of synovium degradation.

Rhein, an active metabolite of diacerein, down-regulates the production of pro-matrix metalloproteinases-1, -3, -9 and -13 and up-regulates the production of tissue inhibitor of metalloproteinase-1 in cultured rabbit articular chondrocytes.

The effects of orally administered diacerein on cartilage and subchondral bone in an ovine model of osteoarthritis.

P304

857-861

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ARD.2003.007302

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P577

2004-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8512134

http://www.w3.org/2001/XMLSchema#string

P698

15194584

http://www.w3.org/2001/XMLSchema#string

P932

1755067

http://www.w3.org/2001/XMLSchema#string